Nationwide
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly and Company
Ph 3·~2yr·30 sites in AZ, CA, CT +15
Eli Lilly and Company
University of Connecticut
Zona Health, Inc
Wayne State University
VA Office of Research and Development
Ohio State University
Massachusetts General Hospital
Milton S. Hershey Medical Center
Brigham and Women's Hospital
University of Alabama at Birmingham
Ohio State University
Christiana Care Health Services
Freda Patterson
Massachusetts General Hospital
Johns Hopkins University
University of Nevada, Las Vegas
University of Colorado, Boulder
University of Colorado, Denver
University of Chicago
Clinical Nutrition Research Center, Illinois Institute of Technology